GE HealthCare's strong Q2 performance and raised guidance signal a positive outlook for the company. The standalone GEHC should benefit from a number of underlying growth drivers in the future as well. Fast Five hosts Sean Whooley and Danielle Kirsh explain what factors contributed to the company's growth and how analysts view performance and prospects.

NeuroOne Medical Technologies recently announced it priced an underwritten registered public offering. The proceeds from the offering may accelerate NeuroOne's research and development efforts. Find out the size of the offering and how NeuroOne plans to use the funds in today's episode. 

Ra Medical's increasing demand for its noninvasive electrophysiology mapping system signifies the healthcare industry's emphasis on less invasive procedures and patient-centered care. Whooley explains what product line has had increased use and what expansion efforts the company has undertaken to grow. 

Baxter this week picked “Vantive” as the name of its proposed kidney care spinoff. The Fast Five hosts discuss when the spinoff is supposed to wrap up, how the company will operate until then and who has been chosen to lead the company. 

The appointment of a CEO for 3M's Health Care spinoff is a significant milestone in the process of establishing the new entity's leadership and direction. Find out what steps have been taken in preparation for the planned spinoff and what the sales revenue for the division was in Q2.

Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.